309 related articles for article (PubMed ID: 16979139)
21. Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?
Deutsch SI; Urbano MR; Neumann SA; Burket JA; Katz E
Clin Neuropharmacol; 2010 May; 33(3):114-20. PubMed ID: 20190638
[TBL] [Abstract][Full Text] [Related]
22. Nicotinic receptors in aging and dementia.
Picciotto MR; Zoli M
J Neurobiol; 2002 Dec; 53(4):641-55. PubMed ID: 12436427
[TBL] [Abstract][Full Text] [Related]
23. Nicotinic acetylcholine receptors as targets for antidepressants.
Shytle RD; Silver AA; Lukas RJ; Newman MB; Sheehan DV; Sanberg PR
Mol Psychiatry; 2002; 7(6):525-35. PubMed ID: 12140772
[TBL] [Abstract][Full Text] [Related]
24. Nicotinic acetylcholine receptors: an overview on drug discovery.
D'hoedt D; Bertrand D
Expert Opin Ther Targets; 2009 Apr; 13(4):395-411. PubMed ID: 19335063
[TBL] [Abstract][Full Text] [Related]
25. Nicotinic receptors, allosteric proteins and medicine.
Changeux JP; Taly A
Trends Mol Med; 2008 Mar; 14(3):93-102. PubMed ID: 18262468
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic cholinergic antagonists: a novel approach for the treatment of autism.
Lippiello PM
Med Hypotheses; 2006; 66(5):985-90. PubMed ID: 16406687
[TBL] [Abstract][Full Text] [Related]
27. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
[TBL] [Abstract][Full Text] [Related]
28. Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors.
Brown LA; Ihara M; Buckingham SD; Matsuda K; Sattelle DB
J Neurochem; 2006 Oct; 99(2):608-15. PubMed ID: 16899070
[TBL] [Abstract][Full Text] [Related]
29. Agonist actions of neonicotinoids on nicotinic acetylcholine receptors expressed by cockroach neurons.
Tan J; Galligan JJ; Hollingworth RM
Neurotoxicology; 2007 Jul; 28(4):829-42. PubMed ID: 17561262
[TBL] [Abstract][Full Text] [Related]
30. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
[TBL] [Abstract][Full Text] [Related]
31. Desensitized nicotinic receptors in brain.
Wang H; Sun X
Brain Res Brain Res Rev; 2005 Jun; 48(3):420-37. PubMed ID: 15914250
[TBL] [Abstract][Full Text] [Related]
32. Regulation of neuronal nicotinic receptor traffic and expression.
Gaimarri A; Moretti M; Riganti L; Zanardi A; Clementi F; Gotti C
Brain Res Rev; 2007 Aug; 55(1):134-43. PubMed ID: 17383007
[TBL] [Abstract][Full Text] [Related]
33. alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?
Paleari L; Cesario A; Fini M; Russo P
Drug Discov Today; 2009 Sep; 14(17-18):822-36. PubMed ID: 19616116
[TBL] [Abstract][Full Text] [Related]
34. Neuronal nicotinic receptor subtypes: defining therapeutic targets.
Buccafusco JJ
Mol Interv; 2004 Oct; 4(5):285-95. PubMed ID: 15471911
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
Bunnelle WH; Daanen JF; Ryther KB; Schrimpf MR; Dart MJ; Gelain A; Meyer MD; Frost JM; Anderson DJ; Buckley M; Curzon P; Cao YJ; Puttfarcken P; Searle X; Ji J; Putman CB; Surowy C; Toma L; Barlocco D
J Med Chem; 2007 Jul; 50(15):3627-44. PubMed ID: 17585748
[TBL] [Abstract][Full Text] [Related]
36. 7-Azaindole derivatives as potential partial nicotinic agonists.
Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG
Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307
[TBL] [Abstract][Full Text] [Related]
37. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
38. The wonderland of neuronal nicotinic acetylcholine receptors.
Bertrand D; Terry AV
Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596
[TBL] [Abstract][Full Text] [Related]
39. Allosteric modulation of nicotinic acetylcholine receptors.
Chatzidaki A; Millar NS
Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
[TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapy for tobacco dependence.
Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
